Melanoma Flashcards
What is the pathogenesis of Melanomia?
- Melanocytes [located on skin, eye,…] help with protecting the tissues from UV radiation induced damage –> malignant transformation
What are some of the risk factors for Melanomia?
- Genetics [FAMMS or HDNS]
- Sun [UV B light: SUNSCREEN protects]
- Internittent overexposure [skin is not use to it]
What are some of the types of Melanoma that can form?
- Superficial Spreading
- Nodular
- Lentigo Maligna
- Acral Lentiginous
- Uveal
What is Superficial Spreading Melanoma?
- Most common [70%]
- Flat, Irregular, Asymmetrical
- RAPID growth
What is Nodular Melanoma?
- 15% - Aggressive
- Dark blue-black
- Located on Head, Neck, Trunk
What is Lentigo Malinga Melanoma?
- On the face
- Brown
What is Acral Lentiginous Melanoma?
- On palms, soles, under nails beds
- MORE common in African Americans, Asians, and Hispanics
What is Uveal Melanoma?
- Within the eye
- Metastasis to liver
What are the ABCDE’s of Melanoma?
- A: Asymmetric [not round]
- B: Borders
- C: Colors [black, blue, brown, yellow…]
- D: Diameter [Growth?]
- E: Evolution [change over time]
If a skin lesion is suspected, what is the way to remove it?
- Digging it out
- Thin slices on exposed areas
- CHECK BRAF
What is the way that we are able to surgically remove Melanoma?
- Dig out
- Mohs Surgery [thin slices]
What is the treatment overview for Melanoma?
- Stage I or IIA [Early]: Clinical trail or observe
- Stage IIB or IIC [Early]: Clinical trail, Observe, Pembrolizumab]
- Stage III [Early]: Nivolumab, Pembrolizumab or Dabrafrnib/Trametinib
In what way was Nivolumab chosen over Ipilimumab in Adjuvant therapy for Melanoma?
- Based on Checkmate 238 Trial
- Ipilimumab has more toxicities –> Use Nivolumab Alone
In what way was Pembrolizumab chosen over Ipilimumab in Adjuvant therapy for Melanoma?
- Pembrolizumab approved for Stage III resected
What is the use for Adjuvant Dabrafenib/Trametinib in Melanona?
- Completely resected, stage II disease with BRAF V600
Why cant you use Dabrafinib alone in Melanoma?
- Dabrafinib can cause BRAF to activate in normal cells = skin cancer
- Trametinib inhibits MEK stopping this from happening
What are some of the 1st line treatment options for Metastatic Melanoma?
- PD-1 inhibitors [Nivolumab or Pembrolizumab]
- BRAF + MEK [ONLY if BRAF Mutation]
- Nivolumab/Ipilimumab [maybe - high toxicities]
What are some of the 2nd line treatment options for Metastatic Melanoma?
- Same as 1st line?
- Chemo [ONLY IF NEED BE - Paclitaxel]
What do we start with first, when treating Melanoma?
- Immunotherapy should be started first then BRAF Mutation if there is a mutation [BRAF - is quick; Immunotherapy - takes weeks]
What are the BRAF inhibitor that are used in Melanoma?
- VermuRAFenib, DaBRAFenib, EncoRAFenib
What are the MEK inhibitors that are used in Melanoma?
- Trametinib, Cobimetinib, Binimetinib
What is Vemurafenib?
- BRAF kinase Inhibitor taken WITH Cobmietinib
- QTc Prolongation
- Secondary Skin Cancers
What is Cobmietinib?
- MEK inhibitor for unresectable or metastatic Melanoma
- Used with Vemurafenib
What is Dabrafenib?
- BRAF Kinase Inhibitor taken WITH Trametinib
- Secondary Skin Cancers
What is Trametinib?
- MEK Inhibitor that is selective for MEK 1 & 2 –> decreasing cell proliferation and increases apoptosis
- Used with Dabrafenib
What is Encorafenib?
- BRAF Kinase Inhibitor taken WITH Binimetinib [1st line?]
- Causes less fever [fevers affect dosages]
What is Binimetinib?
- MEK-1 Inhibitor that is used in combo with Encorafenib
- Less fevers [Affects dosages]
What is important to know about the BRAF inhibitors?
- Taken alone, resistance can develop in 6 months - why we take MEK inhibitor with it
What is Ipilimumab?
- CTLA-4: down regulates the T-cell activation promoting antitumor immunity
- Approved in unresectable and metastatic
What are some of the toxicites that can show from taking Immunotherapy in Melanoma?
- Immune Mediated Colitis
- Immune Mediated Diabetes
- Immune Mediated Hypophysitis
EXAMPLE: What would the regimen be for a patient that has Stage II melanoma?
- Pembrolizumab or Surgery or Observation for 1 YEAR
EXAMPLE: What would the regimen be for a patient that has Stage III Melanoma?
- BRAF Mutation or NAH
- NO: Pembrolizumab
- YA: Pembrolizumab + Dabrafinib/Trametinib or Observation
EXAMPLE: What would the regimen be for first line metastatic melanoma
- BRAF Mutation or NAH
- NO: Pembrolizumab
- YA: Pembrolizumab + BRAF/MEK